SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start

level: Level 1

Questions and Answers List

level questions: Level 1

QuestionAnswer
SPECIES of plasmodium that are human pathogensPLAsmodium ( falciparum,vivax,ovale,malariae, kowlesii, cynomolgi)
mode of transmission of malariafrom person to person by the ANOPHELINE mosquito, by contaminated needles, blood transfusion and organ transplant.
distribution of malariatropical regions of sub saharan africa, asia, oceania and latin america
epidemic determinants factors of malaria1)drought 2) elevated drug resistance 3) abnormal temperature 4) land pattern changes 5) high malnutrition rates
species virulence factor of plasmodium sp.1)antigenic variation 2) drug resistance, 3)cytoadherence of infected rbc, 4)intracellular multiplication 5) life cycle
4 stages of malaria parasite1) exo-erythrocytic stage 2) erythrocytic stage 3)sexal/asexual stage 4) sporogenic stage
where does the sporogenic stage of the malaria paraiste life cycle takes placein the malaria: after injection of gametocytes from the transport host, they mature into : microgametocyte- microgametocyte with exflagellate- macrogametocyte- ookinen- oocyct- sporozoites.
describe the human stage of the malaria parasite life cycle:infection occurs when malaria takes a meal an injects the sporozoites into the human. human liver stage is the exo-erythrocytic stage: where sporozoites develop into schizont in the liver cells. schizonts rupture and enter into the Erythrocytic stage in the human rbc; where trophozoites develop into gametocytes.
what is the infective stage of the malaria parasitesporozoites injected into the blood stream when mosquito takes a meal
what is the diagnostic stage of the malaria parasitewhen the parasite enters the erthrocytic stage in the rbc. schizont develops into gametocytes.
what is the gold standard laboratory diagnosis of malaria parasitethick or thin BF with Giemsa/hematoxillin stain and whole blood and look for trophozoites and gametocytes in the : cytoplasm, nucleus for schuffners dot and pigments which indicate the presence of the parasite
OTHER lab and serological methods for screening for malaria parasite1)used to detect antibodies: limited because antibodies may be absent in acute infection. 2)antigen detection is a rapid test that may tell the presence of the parastate but not the species 3)PCR 4) detection using fluorescent dyes: using the kwamato technique to stained with acridine orange or BCT(benzo. DNA stain green and cytoplasmic RNA stain red. viewing in done with a florescent microscope or light microscope with an interference filter. limited because florescent microscopes are expensive. 5) buffy coat method the benefit of testing is in early treatment
treatment of malaria infectiondepends on the stage of the reproductive cycle exo-erythrocytic stage/ tissue schizonticiedes: PRIMAQUINE ERYTHROCITIC STAGE/ BLOOD SCHIZONTICIDE: CHLOROQUINE PHOPSHATE. if resistant to chloroquine, use ; MEFLOQUINE, DOXYCYCLINE, QUININE, PYREMETHAMINE HALOFANTINE ARTEMISININ, ATOVAQUONE GEMETOCYTOCIDAL: USE QUININE GLUCONATE, ARTESUNATE, QUININE DIHYDORCHLORIDE, ARTEMETHER
TREATMENT IN THE ERYTHOCITIC STAGEERYTHROCITIC STAGE/ BLOOD SCHIZONTICIDE: CHLOROQUINE PHOPSHATE. if resistant to chloroquine, use ; MEFLOQUINE, DOXYCYCLINE, QUININE, PYREMETHAMINE HALOFANTINE ARTEMISININ, ATOVAQUONE
GEMETOCYTOCIDAL TREATMENTUSE QUININE GLUCONATE, ARTESUNATE, QUININE DIHYDORCHLORIDE, ARTEMETHER
TISSUE SCHIZONTICIDES TREATMENTPRIMAQUINE
COMPLICATION Of malariaanaemia: very severe in P falciparum cns involvement: present and usually sever in P. flacilparum nephrotic syndrome: always present in P. malariae hypoglycemia pulmonary edema, respiratory distress, metaboloc acidosis malaria pregnancy
prevention;chomoprophylaxis, ppe, avoidance and vaccines use trimethroprine/ cortimoxazole in hiv patients
the group that P.vivax does not infect?individual who lack Duffy antigens on the surface of their rbc, especially black people
prevention of malaria infection in hiv patients?use trimethroprine/ cortimoxazole in hiv patients